Grant: Operating Grant
University of Calgary
$100,000.00
Smooth muscle-myofibroblast transition in asthma
FY 2015-16
Summary
Background: Asthma is the most common chronic respiratory disease in Canada, causing 80% of chronic respiratory disease and affecting 8.4% of the population and costs Canadian health care system approximately $ 2 billion/year. In addition, the prevalence of asthma appears to be increasing. People with asthma have difficulty with breathing when they inhale substances called allergens. Asthmatics have increased smooth muscle and scarring in their airways, termed 'airway remodeling'. The scarring is believed to be related to increased numbers of cells called myofibroblasts. We have previously found that allergen inhalation in asthmatics produces a large number of myofibroblasts which appeared to arise from the smooth muscle in the airway. We hypothesize that allergen stimulates airway epithelial cells to produce mediators which cause changes in the smooth muscle leading to the production of myofibroblasts and more scarring. Objective: We will examine the effect of allergen on epithelial cells and whether the substances they produce stimulate the conversion of smooth muscle cells to myofibroblasts which then travel towards the epithelium. Methods: We will use cultured human bronchial epithelial and smooth muscle cells. Initially we will stimulate the epithelial cells with an allergen that commonly causes asthmatic exacerbations, derived from house dust mites. We will then take the secretions from the epithelial cells and observe the effect on smooth muscle cells and whether myofibroblasts are produced. We will also undertake biopsy studies in asthmatic subjects after allergen challenge and observe whether myofibroblasts can be seen to arise directly from smooth muscle. Relevance: Current medications for asthma do not prevent the scarring of the airways seen in patients with asthma. Our studies will provide information about the derivation of the myofibroblast and hopefully ways to intervene and prevent their formation, leading to the development of new therapies.
Department
Program
Operating Grant
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
332989
Name
Kelly Margaret M
Region
Alberta
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Respiratory System
Projecttitle
Smooth muscle-myofibroblast transition in asthma
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Airway Remodeling; Allergen Challenge; Asthma; Cell Culture; Cell Migration; Endobronchial Biopsy; Immunohistochemistry; Myofibroblasts; Smooth Muscle
Abstract
Background: Asthma is the most common chronic respiratory disease in Canada, causing 80% of chronic respiratory disease and affecting 8.4% of the population and costs Canadian health care system approximately $ 2 billion/year. In addition, the prevalence of asthma appears to be increasing. People with asthma have difficulty with breathing when they inhale substances called allergens. Asthmatics have increased smooth muscle and scarring in their airways, termed 'airway remodeling'. The scarring is believed to be related to increased numbers of cells called myofibroblasts. We have previously found that allergen inhalation in asthmatics produces a large number of myofibroblasts which appeared to arise from the smooth muscle in the airway. We hypothesize that allergen stimulates airway epithelial cells to produce mediators which cause changes in the smooth muscle leading to the production of myofibroblasts and more scarring. Objective: We will examine the effect of allergen on epithelial cells and whether the substances they produce stimulate the conversion of smooth muscle cells to myofibroblasts which then travel towards the epithelium. Methods: We will use cultured human bronchial epithelial and smooth muscle cells. Initially we will stimulate the epithelial cells with an allergen that commonly causes asthmatic exacerbations, derived from house dust mites. We will then take the secretions from the epithelial cells and observe the effect on smooth muscle cells and whether myofibroblasts are produced. We will also undertake biopsy studies in asthmatic subjects after allergen challenge and observe whether myofibroblasts can be seen to arise directly from smooth muscle. Relevance: Current medications for asthma do not prevent the scarring of the airways seen in patients with asthma. Our studies will provide information about the derivation of the myofibroblast and hopefully ways to intervene and prevent their formation, leading to the development of new therapies.
Competitiondate
201505
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kelly, Margaret M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~